Renal Cancer - Results from #5720

The Involvement of PDGF-B/PDGFRβ Axis in the Resistance to Antiangiogenic and Antivascular Therapy in Renal Cancer. May 4, 2016

Proteotranscriptomic Analysis Reveals Stage Specific Changes in the Molecular Landscape of Clear-Cell Renal Cell Carcinoma May 3, 2016

Validation of DAB2IP methylation and its relative significance in predicting outcome in renal cell carcinoma May 3, 2016

The Content and Quality of Health Information on the Internet for Patients and Families on Adult Kidney Cancer May 2, 2016

Optimizing clinical benefit with targeted treatment in mRCC: "Tumor growth rate" as an alternative clinical endpoint May 2, 2016

Primary carcinoma of the ureteral stump following radical nephrectomy for renal cell carcinoma: A case report and literature review May 1, 2016

Reproducibility of the NEPTUNE descriptor-based scoring system on whole-slide images and histologic and ultrastructural digital images April 28, 2016

Circulating Tumor Cell Composition in Renal Cell Carcinoma April 28, 2016

Association of Angiopoietin-2 and Ki-67 Expression with Vascular Density and Sunitinib Response in Metastatic Renal Cell Carcinoma April 28, 2016

Tumor control with PD-1 inhibition in a patient with concurrent metastatic melanoma and renal cell carcinoma April 28, 2016

Prospective MR image alignment between breath-holds: Application to renal BOLD MRI April 28, 2016

Loss of Fumarate Hydratase and Aberrant Protein Succination Detected With S-(2-Succino)-Cysteine Staining to Identify Patients With Multiple Cutaneous and Uterine Leiomyomatosis and Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome April 28, 2016

Renal cell carcinoma: Are we attacking a different tumor over the past 10 years? April 27, 2016

Impact of Second-Line Targeted Therapy Dose Intensity on Patients With Metastatic Renal Cell Carcinoma April 27, 2016

Dual Roles of 17-β Estradiol in Estrogen Receptor-dependent Growth Inhibition in Renal Cell Carcinoma. April 26, 2016

SATB1 is Down-regulated in Clear Cell Renal Cell Carcinoma and Correlates with miR-21-5p Overexpression and Poor Prognosis April 26, 2016

The Evolution of Nephrectomy and Patient Characteristics in Metastatic Renal Cell Carcinoma Patients Enrolled Into First-Line Tyrosine Kinase Inhibitors Clinical Trials April 26, 2016

Targeted dual-modality imaging in renal cell carcinoma: An ex vivo kidney perfusion study April 26, 2016

FDA Approves Cabozantinib Tablets For Patients with Advanced Renal Cell Carcinoma Who Have Received Prior Anti-angiogenic Therapy April 25, 2016

Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution April 25, 2016

Page 287 of 456